We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




The Adult Heart Lacks Stem Cells Capable of Regenerating Damaged Muscle

By LabMedica International staff writers
Posted on 16 Aug 2012
A recent study conducted on mice has shown that stem cells present in the hearts of new born animals can be induced to regenerate heart muscle following a heart attack but that these stem cells no longer function in the hearts of adult animals.

Investigators at Cornell University (Ithaca, NY, USA) and their colleagues at the University of Bonn (Germany) examined the ability of neonatal and adult mice to regenerate heart muscle tissue following heart attack (infarction) to determine the role of the stem cells known as c-kit+ cardiovascular precursor cells (CPCs) that are known to be present in early heart development.

They reported in the July 30, 2012, online edition of the journal Proceedings of the National Academy of Sciences of the USA (PNAS) that undifferentiated precursor cells matured into new heart muscle cells in two-day-old mice, but not in adult animals. More...
While the young mice were able to regenerate functional myocytes, infarction of adult mice resulted in only a modest induction of c-kit+ cells within the infarct, which did not undergo myogenic differentiation, but adopted a vascular role within the infarction, indicating a lack of authentic CPCs.

“While the existence of these cells in adults is controversial, if one did have fully capable stem cells in adults, why are there no new heart cells after an infarct? Whether this is due to a lack of stem cells or to something special about the infarct that inhibits stem cells from forming new heart cells is the question we addressed, taking advantage of the fact that the newborn mouse has these cells,” said senior author Dr. Michael Kotlikoff, professor of veterinary medicine at Cornell University. “The stem cells found in the adult heart have lost the ability to become heart cells, and are only capable of forming new vessels.”

Related Links:
Cornell University
University of Bonn


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: Associate Professor Arutha Kulasinghe and non-small cell lung cancer cell (Photo courtesy of The University of Queensland)

Blood-Based Proteomic Test May Predict Treatment Response in Non-Small Cell Lung Cancer

Lung cancer remains the leading cause of cancer death, with non-small cell lung cancer (NSCLC) accounting for most cases. Treatment decisions are often made without a clear indication of how a patient... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.